The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The incidence and risk factors predictive of bone metastases at initial diagnosis of malignancy.
 
Brendan Knapp
No Relationships to Disclose
 
Mary Ellen Flanagan
No Relationships to Disclose
 
Nikhil Grandhi
No Relationships to Disclose
 
Bharath Ganesh
No Relationships to Disclose
 
Giordano Fabricio Cittolin Santos
No Relationships to Disclose
 
Feng Gao
No Relationships to Disclose
 
Pamela P. Samson
Honoraria - AstraZeneca; Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
 
Ramaswamy Govindan
Consulting or Advisory Role - Jacobio; Merck; Precisca
 
Daniel Morgensztern
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb/Medarex
Consulting or Advisory Role - Abbvie; Arcus Biosciences; Bristol-Myers Squibb; G1 Therapeutics; Lilly Medical; Mirati Therapeutics
Research Funding - Abbvie (Inst); Altum Pharmaceuticals (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Baxter (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EpicentRx (Inst); Heat Biologics (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Surface Oncology (Inst); Y-mAbs Therapeutics (Inst)